Arthritis Society Canada

220 Bay Street, Suite 300
Toronto, ON M5J 2W4
President & CEO: Trish Barbato
Board Chair: Andrew Branion

Charitable Reg. #:10807 1671 RR0003

STAR RATING

Ci's Star Rating is calculated based on the following independent metrics:

[Charity Rating: 3/5]

✔+

FINANCIAL TRANSPARENCY

Audited financial statements for current and previous years available on the charity’s website.

A-

RESULTS REPORTING

Grade based on the charity's public reporting of the work it does and the results it achieves.

n/r

DEMONSTRATED IMPACT

The demonstrated impact per dollar Ci calculates from available program information.

NEED FOR FUNDING

Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.

56%

CENTS TO THE CAUSE

For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 56 cents are available for programs.



My anchor

OVERVIEW

About Arthritis Society Canada:

Arthritis Society Canada is a 3-star charity that is financially transparent. It has an A- results reporting grade, which is above average. Its reserve funds could cover annual program costs for just over five months, which is within Ci’s reasonable range. Its overhead spending is outside of Ci’s reasonable range.

Founded in 1948, Arthritis Society Canada (ASC) funds arthritis research, advocates for policy change, and provides support to improve health among those infected with arthritis. Arthritis is a collection of conditions affecting joints and other tissues. It causes pain, restricts mobility, and diminishes quality of life. Arthritis Society Canada reports that one in five Canadians live with arthritis. There is currently no cure. The charity runs four main programs: Research, Innovation, Advocacy, and Information and Support.

Financial information is based on the most recently available audited financial statements for the fiscal year ending March 2026 (F2026). Program results are from the charity’s F2025 impact report, the most recent impact report available at the time of this update.

In F2025, ASC spent $19.1m on its programs. Research represented 37% of program spending and the remaining 63% went to Innovation, Advocacy, and Information and Support.

Research: ASC’s Research focuses on pain relief, osteoarthritis (most common form of arthritis) and inflammatory arthritis. In F2025, ASC had 113 active research projects which included 64 grants, 38 training awards, 10 career developments, and one team grant. These research projects supported 345 researchers: 114 lead researchers, 111 additional trainees, and 120 qualified research personnel.

Innovation: The Innovation program funds social impact projects to uncover ideas to help people living with arthritis. In F2025, ASC reported committing $599,450 to six new Ignite Research Grants. Its Newborn Arthritis Prevention Screening (NAPS) project performed more than 2,000 scans on 1,800 infants.

Advocacy: ASC advocates on behalf of Canadians affected by arthritis to drive policy and raise awareness. In F2025, ASC completed 8,558 advocacy actions, engaged with 73 political and policy representatives, submitted eight pre-budget recommendations, and participated in eight government consultations.

Information and Support: ASC provides evidence-based information, resources, and online tools for people affected by arthritis. In F2025, the charity delivered 5,635 public service announcements to raise awareness. Its website had 1,696,965 visitors, and its newsletter had 126,869 subscribers. Arthritis Talks reached 65,322 people. ASC also operates six camps across Canada for children with arthritis, serving 328 campers in F2025.

My anchor

Results and Impact

In F2025, Arthritis Society Canada’s NAPS project identified 45 cases of hip dysplasia, including 29 that would likely have otherwise gone undetected.

In 2023, Arthritis Society Canada released a report highlighting the problem of wait times arthritis patients face at the hospital. The charity reports 38% of Canadians did not receive their hip or knee joint replacement surgery within the recommended time of six months. The report provided recommendations to provincial and federal governments. The government included many of Arthritis Society’s recommendations in F2022. In March 2022, the federal government added an additional $2 billion to address the backlogs in arthritis surgeries. Nine provinces implemented the charity's recommended GLA:D education and exercise program. 70% of the patients reported significantly improved function.

On its website, ASC published its top ten research advancements for 2023. ASC found an enzyme called Tryptase B which may contribute to osteoarthritis by interfering with the anti-inflammatory and joint-lubricating activities of a protein called PRG4. ASC also found out that small particles made from a type of molecule called polyphosphate can be used to effectively deliver drugs into the cartilage that pads the joints, which was typically a hard-to-reach area for drugs. To learn about the other advancements made in 2023-2024, go through the resources Charity Intelligence provides in the “Learn More” section at the bottom of the webpage. 

While Ci highlights these key results, they may not be a complete representation of Arthritis Society Canada’s results and impact. This charity is not yet rated on impact (n/r). This not rated for impact does not affect Arthritis Society Canada's overall star rating.

My anchor

Finances

Arthritis Society Canada received $26.0m in donations in F2026, which is 76% of total revenue. It also received $6.4m in government funding, representing 19% of total revenue.

In F2026, ASC spent $17.2m on programs and grants, accounting for 50% of total revenue. The charity ran a surplus of $4.6m, which was 13% of total revenue.

Fundraising costs were $9.1m, which is 35% of donations, and administrative costs were $3.1m, which is 9% of revenue (excluding investment income). Total overhead spending was 44%, meaning that for every dollar donated, 56 cents are available to go to the cause. This is outside of Ci’s reasonable range, which suggests 65-95 cents per dollar. The charity has been outside the reasonable range since 2013. 

At the end of F2026, ASC had $9.8m in reserve funds (cash and investments), including $2.4m of donor-endowed funds. Excluding donor-endowed funds, its reserves could cover annual program costs for just over five months, which is within Ci’s reasonable range. ASC has committed $8.9m to research over the next three years.

ASC uses external fundraisers.The F2026 T3010 filing was not available at the time of this update, so these figures are based on F2025. In F2025, ASC paid $718k to external fundraisers to raise $1.3m, meaning the cost to raise a dollar via external fundraisers is 57 cents. It is likely more efficient to donate directly to the charity.

Comments and corrections may be forthcoming. Profile updated on July 20, 2026 by Ava Anderson.

Financial Review


Financial Ratios

Fiscal year ending March
202620252024
Administrative costs as % of revenues 9.2%13.0%13.5%
Fundraising costs as % of donations 35.2%48.7%44.6%
Total overhead spending 44.4%61.6%58.0%
Program cost coverage (%) 43.6%15.7%3.0%

Summary Financial Statements

All figures in $000s
202620252024
Donations 25,97920,07821,052
Government funding 6,3605,9317,356
Investment income 0272388
Other income 1,7623,303(911)
Total revenues 34,10129,58427,886
Program costs 10,38311,60111,752
Grants 6,7737,5046,565
Administrative costs 3,1383,8113,702
Fundraising costs 9,1429,7679,380
Other costs 7100
Total spending 29,50732,68331,399
Cash flow from operations 4,595(3,099)(3,513)
Capital spending 161(4,713)741
Funding reserves 9,8245,3722,924

Note: DEFERRED DONATIONS: To report on a cash-basis, Ci adjusts for deferred contributions. This affected total revenues by $220k in F2026, $1.7m in F2025, and ($2.7m) in F2024. Ci removed these deferred contributions from Other Revenue because it was unclear if they were donations or governmental funding. ENDOWMENT CONTRIBUTIONS: Ci adjusted for endowment contributions impacting total revenues by $nil in F2026, ($4k) in F2025, and ($5k) in F2024. RESEARCH AWARDS PAYABLE: Ci adjusted for research awards payable affecting grants by $nil in F2026, $473k in F2025, and $7k in F2024. AMORTIZATION: ASC did not separately report amortization on its income statement. Ci removed amortization from program, administrative, and fundraising costs on a pro-rata basis.

Salary Information

Full-time staff: 133

Avg. compensation: $93,752

Top 10 staff salary range:

$350k +
1
$300k - $350k
2
$250k - $300k
1
$200k - $250k
3
$160k - $200k
3
$120k - $160k
0
$80k - $120k
0
$40k - $80k
0
< $40k
0

Information from most recent CRA Charities Directorate filings for F2025

My anchor

Comments & Contact

Comments added by the Charity:

Charity Contact

Website: www.arthritis.ca
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 416-979-7228 

Print  
Image

Charity Intelligence researches Canadian charities for donors to be informed and give intelligently. Our website posts free reports on more than 800 Canadian charities, as well as in-depth primers on philanthropic sectors like Canada’s environment, cancer, and homelessness. Today over 400,000 visitors use our website as a go-to source for information on Canadian charities reading over 1.5 million charity reports. Through rigorous and independent research, Charity Intelligence aims to assist Canada’s dynamic charitable sector in being more transparent, accountable and focused on results.

 

Be Informed. Give Intelligently. Have Impact

 

Charitable Registration Number: 80340 7956 RR0001